Letter: Programmed Cell Death Protein-1 (PD-1)-targeted Immunotherapy in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data From an International Multicentre Real-World Cohort-More Questions Than Answers
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15322
Full Text
Open PDFAbstract
Available in full text
Date
June 27, 2019
Authors
Publisher
Wiley